Benjamin M. Marlin

Prof. Benjamin M. Marlin

University of Massachusetts Amerst
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2020 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
OIOmer Inan
Omer Inan
PTP. Tenaerts
P. Tenaerts
SPS. A. Prindiville
S. A. Prindiville
HRH. R. Reynolds
H. R. Reynolds
DDD. S. Dizon
D. S. Dizon
RCR. M. Califf
R. M. Califf
Clinical trials are a fundamental tool used to evaluate the efficacy and safety of new drugs and medical devices and other health system interventions. The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system interventions. The concept of a “digital clinical trial” involves leveraging digital technology to improve participant access, engagement, trial-related measurements, and/or interventions, enable concealed randomized intervention allocation, and has the potential to transform clinical trials and to lower their cost. In April 2019, the US National Institutes of Health (NIH) and the National Science Foundation (NSF) held a workshop bringing together experts in clinical trials, digital technology, and digital analytics to discuss strategies to implement the use of digital technologies in clinical trials while considering potential challenges. This position paper builds on this workshop to describe the current state of the art for digital clinical trials including (1) defining and outlining the composition and elements of digital trials; (2) describing recruitment and retention using digital technology; (3) outlining data collection elements including mobile health, wearable technologies, application programming interfaces (APIs), digital transmission of data, and consideration of regulatory oversight and guidance for data security, privacy, and remotely provided informed consent; (4) elucidating digital analytics and data science approaches leveraging artificial intelligence and machine learning algorithms; and (5) setting future priorities and strategies that should be addressed to successfully harness digital methods and the myriad benefits of such technologies for clinical research.

2 June 2014
Verified
Conference Paper
Open access
AMAddison Mayberry
Addison Mayberry
PHPan Hu
Pan Hu
Benjamin M. MarlinBenjamin M. Marlin
Benjamin M. Marlin
CSChristopher Salthouse
Christopher Salthouse
DGDeepak Ganesan
Deepak Ganesan
Continuous, real-time tracking of eye gaze is valuable in a variety of scenarios including hands-free interaction with the physical world, detection of unsafe behaviors, leveraging visual context for advertising, life logging, and others. While eye tracking is commonly used in clinical trials and user studies, it has not bridged the gap to everyday consumer use. The challenge is that a real-time eye tracker is a power-hungry and computation-intensive device which requires continuous sensing of the eye using an imager running at many tens of frames per second, and continuous processing of the image stream using sophisticated gaze estimation algorithms. Our key contribution is the design of an eye tracker that dramatically reduces the sensing and computation needs for eye tracking, thereby achieving orders of magnitude reductions in power consumption and form-factor. The key idea is that eye images are extremely redundant, therefore we can estimate gaze by using a small subset of carefully chosen pixels per frame. We instantiate this idea in a prototype hardware platform equipped with a low-power image sensor that provides random access to pixel values, a low-power ARM Cortex M3 microcontroller, and a bluetooth radio to communicate with a mobile phone. The sparse pixel-based gaze estimation algorithm is a multi-layer neural network learned using a state-of-the-art sparsity-inducing regularization function that minimizes the gaze prediction error while simultaneously minimizing the number of pixels used. Our results show that we can operate at roughly 70mW of power, while continuously estimating eye gaze at the rate of 30 Hz with errors of roughly 3 degrees.

8 November 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RSRajani Shankar Sadasivam
Rajani Shankar Sadasivam
EBErin M Borglund
Erin M Borglund
RARoy Adams
Roy Adams
Benjamin M. MarlinBenjamin M. Marlin
Benjamin M. Marlin
THThomas K Houston
Thomas K Houston
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 September 2015
Verified
Conference Paper
Closed access
NSNazir Saleheen
Nazir Saleheen
AAAmin Ahsan Ali
Amin Ahsan Ali
SHSyed Monowar Hossain
Syed Monowar Hossain
HSHillol Sarker
Hillol Sarker
SCSoujanya Chatterjee
Soujanya Chatterjee
SKSantosh Kumar
Santosh Kumar

7 March 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RSRajani Shankar Sadasivam
Rajani Shankar Sadasivam
SCSarah L Cutrona
Sarah L Cutrona
RKRebecca L Kinney
Rebecca L Kinney
Benjamin M. MarlinBenjamin M. Marlin
Benjamin M. Marlin
KMKathleen M Mazor
Kathleen M Mazor
THThomas K Houston
Thomas K Houston
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

DSDonna Spruijt-Metz
Donna Spruijt-Metz
Benjamin M. MarlinBenjamin M. Marlin
Benjamin M. Marlin
MPMisha Pavel
Misha Pavel
DRDaniel E. Rivera
Daniel E. Rivera
EHEric Hekler
Eric Hekler
PKPredrag Klasnja
Predrag Klasnja
Background: Recent advances in mobile and wearable technologies have led to new forms of interventions, called “Just-in-Time Adaptive Interventions” (JITAI). JITAIs interact with the individual at the most appropriate time and provide the most appropriate support depending on the continuously acquired Intensive Longitudinal Data (ILD) on participant physiology, behavior, and contexts. These advances raise an important question: How do we model these data to better understand and intervene on health behaviors? The HeartSteps II study, described here, is a Micro-Randomized Trial (MRT) intended to advance both intervention development and theory-building enabled by the new generation of mobile and wearable technology. Methods: The study involves a year-long deployment of HeartSteps, a JITAI for physical activity and sedentary behavior, with 96 sedentary, overweight, but otherwise healthy adults. The central purpose is twofold: (1) to support the development of modeling approaches for operationalizing dynamic, mathematically rigorous theories of health behavior; and (2) to serve as a testbed for the development of learning algorithms that JITAIs can use to individualize intervention provision in real time at multiple timescales. Discussion and Conclusions: We outline an innovative modeling paradigm to model and use ILD in real- or near-time to individually tailor JITIAs.